ABOUT ELITE
Overview
Our Facility
Management & Key Employees
Our Board
Careers
PRODUCTS
PIPELINE
Generic
Branded
TECHNOLOGY
Technology Overview
How It Works
One Bead System
Two Bead System
INVESTOR RELATIONS
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
HOME
|
CAREERS
|
CONTACT
|
NEWS
|
Skip to content
About Elite
Overview
Management & Key Employees
Our Board
Careers
Products
Pipeline
Generic
Branded
Technology
Technology Overview
How It Works
One Bead System
Two Bead System
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
Investor Relations
Press Releases
Events &Presentations
SEC Filings
ShareholderMeeting
GovernanceDocuments
Investor Contacts
Email Alerts
Press Releases
Select:
Show All
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Archived
Jul 12, 2017
Elite Announces New Development and License Agreement with SunGen Pharma LLC
Jul 07, 2017
Elite Pharmaceuticals Reports Topline Results from a Pivotal Fed Bioequivalence Study for SequestOx™
Jun 14, 2017
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2017 and Provides Conference Call Information
Jun 13, 2017
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results on June 15, 2017
May 31, 2017
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
May 30, 2017
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
May 25, 2017
Elite Pharmaceuticals' SequestOx™ Study Results Expected in July
May 22, 2017
Elite Pharmaceuticals Acquires Trimipramine ANDA
Apr 04, 2017
Elite Pharmaceuticals Files ANDA for Pain Product
Mar 13, 2017
Elite Pharmaceuticals, Inc. Initiates Pivotal Bioequivalence Fed Study for Reformulated SequestOx™
1
2
3
4
5
6
7
8
9
10
11
<<
<
>
>>
Back to top
Privacy
